Produktname:3-methyl-2-[4-(3-methylsulfonylphenyl)phenyl]-5-(trifluoromethyl)quinoxaline
IUPAC Name:2-{3'-methanesulfonyl-[1,1'-biphenyl]-4-yl}-3-methyl-5-(trifluoromethyl)quinoxaline
- CAS:1221265-37-7
- Molekulare Formel:C23H17F3N2O2S
- Reinheit:95%+
- Katalognummer:CM745435
- Molekulargewicht:442.46
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1221265-37-7
- Molekulare Formel:C23H17F3N2O2S
- Schmelzpunkt:-
- SMILES-Code:CC1=C(N=C2C=CC=C(C2=N1)C(F)(F)F)C1=CC=C(C=C1)C1=CC(=CC=C1)S(C)(=O)=O
- Dichte:
- Katalognummer:CM745435
- Molekulargewicht:442.46
- Siedepunkt:
- Mdl-Nr.:MFCD18206803
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.